1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023

The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostic technologies, end-users, and geography. This report studies the current scenario as well as future market potential for endocrine testing globally. This report comprises an elaborate executive summary, which includes a market snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global endocrine testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the endocrine testing market.

Based on test, the global endocrine testing market has been segmented into estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global endocrine testing market has been categorized into North America, Europe, Asia Pacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.

The global endocrine testing market is segmented as follows:

Global Endocrine Testing Market, by Test, 2013-2023 (USD Million)

Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others (Gastrin, Thymosin, Secretin, etc.)
Global Endocrine Testing Market, by Diagnostic Technology, 2013 – 2023 (USD Million)

Tandem Mass spectrometry
Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
Monoclonal and Polyclonal Antibody Technologies
Sensor (Electrochemical, Biosensors, etc.) Technologies
Clinical Chemistry Technologies
Others (Liquid Chromatography + Mass Spectrometry (LC-MS)
Global Endocrine Testing Market, by End User, 2013 – 2023 (USD Million)

Hospitals
Commercial Laboratories
Ambulatory Care Centers
Home Based Tests
Physician Offices
Global Endocrine Testing Market, by Geography, 2013 – 2023 (USD Million)

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Rest of the World (RoW)

Table Of Contents

Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Endocrine Testing Market Revenue, by Diagnostic Technologies, 2014 and 2023 (Value %)
2.2 Global Endocrine Testing Market Revenue, by End-User, 2014 and 2023 (US$ Million)
2.3 Global Endocrine Testing Market Revenue, by Tests, 2014 (US$ Million)
2.4 Global Endocrine Testing Market Revenue, by Geography, 2014 and 2023 (US$ Million)
2.5 Global Endocrine Testing Market, 2014 and 2023: Market Snapshot

Chapter 3 Industry Analysis
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
3.2.1.2 Consistent rise in geriatric population Worldwide
3.2.1.3 Technological advancements
3.2.2 Restraints
3.2.2.1 High cost of technology
3.2.2.2 Lack of healthcare awareness in emerging economies
3.2.3 Opportunity
3.2.3.1 Investment Opportunity
3.2.4 Endocrine Testing Market: Porter's Five Forces Analysis
3.2.5 Market Attractiveness Analysis - Endocrine Testing Market, by Geography, 2014
3.2.6 Competitive Landscape
3.2.6.1 Global Endocrine Testing Market: Market Share, by Key Players, 2014 (%)
3.2.6.2 At Home and Physician Office Endocrine Tests Market Revenue, by Tests, 2014 (US$ Million)

Chapter 4 Market Segmentation - By Tests
4.1 Introduction
4.2 Global Estradiol (E2) Test Market Revenue, 2013-2023 (US$ Mn)
4.3 Global Follicle Stimulating Hormone (FSH) Test Market Revenue, 2013-2023 (US$ Mn)
4.4 Global Human Chorionic Gonadotropin (hCG) Test Market Revenue, 2013-2023 (US$ Mn)
4.5 Global Luteinizing Hormone (LH) Test Market Revenue, 2013-2023 (US$ Mn)
4.6 Global Dehydroepiandrosterone sulfate (DHEAS) Test Market Revenue, 2013-2023 (US$ Mn)
4.7 Global Progesterone Test Market Revenue, 2013-2023 (US$ Mn)
4.8 Global Testosterone Test Market Revenue, 2013-2023 (US$ Mn)
4.9 Global Thyroid Stimulating Hormone (TSH) Test Market Revenue, 2013-2023 (US$ Mn)
4.10 Global Prolactin Test Market Revenue, 2013-2023 (US$ Mn)
4.11 Global Cortisol Test Market Revenue, 2013-2023 (US$ Mn)
4.12 Global Insulin Test Market Revenue, 2013-2023 (US$ Mn)
4.13 Global Other Endocrine Tests Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 Market Segmentation - By Diagnostic Technology
5.1 Global Tandem Mass Spectrometry Market Revenue, 2013-2023 (US$ Mn)
5.2 Global Immunoassay Technologies Market Revenue, 2013-2023 (US$ Mn)
5.3 Global Monoclonal and Polyclonal Antibody Technologies Market Revenue, 2013-2023 (US$ Mn)
5.4 Global Sensor Technologies Market Revenue, 2013-2023 (US$ Mn)
5.5 Global Clinical Chemistry Technologies Market Revenue, 2013-2023 (US$ Mn)
5.6 Global Others Technologies Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 Market Segmentation - By End User
6.1 Global Hospitals Market Revenue, 2013-2023 (US$ Mn)
6.2 Global Commercial Laboratories Market Revenue, 2013-2023 (US$ Mn)
6.3 Global Ambulatory Care Centers Market Revenue, 2013-2023 (US$ Mn)
6.4 Global Home Based tests Market Revenue, 2013-2023 (US$ Mn)
6.5 Global Physician Offices Market Revenue, 2013-2023 (US$ Mn)

Chapter 7 Market Segmentation - By Geography
7.1 Global North America Market Revenue, 2013-2023 (US$ Mn)
7.2 Global Europe Market Revenue, 2013-2023 (US$ Mn)
7.3 Global Asia Pacific Market Revenue, 2013-2023 (US$ Mn)
7.4 Global Rest of the World Market Revenue, 2013-2023 (US$ Mn)

Chapter 8 Recommendations

Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AB Sciex Pte. Ltd.
9.3 Agilent Technologies
9.4 Biomedical Diagnostics
9.5 bioMerieux SA
9.6 Bio-Rad Laboratories, Inc.
9.7 DiaSorin S.p.A.
9.8 F. Hoffmann-La Roche Ltd.
9.9 Laboratory Corporation of America Holdings (LabCorp)
9.10 Ortho-Clinical Diagnostics
9.11 Quest Diagnostics
9.12 Siemens Healthcare GmbH (Siemens AG)
9.13 Sysmex Corporation
9.14 Thermo Fisher Scientific, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.